We recently published a list of Jim Cramer’s List of 16 Stocks to Buy Right Now. In this article, we are going to take a look ...

To get a sense of who is truly in control of Cardinal Health, Inc. (NYSE:CAH), it is important to understand the ownership ...

Citi analyst Daniel Grosslight maintained a Hold rating on Cardinal Health (CAH – Research Report) today and set a price target of $140.00. The ...

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Cardinal Health (CAH – Research Report), with a price ...

A recent selloff of Neurocrine Biosciences stock feels unwarranted and may have created a contrarian buy opportunity. Learn ...

The South San Francisco biotech has acquired rights to tralesinidase alfa, an enzyme replacement therapy (ERT) for the ...

Yes, I do think we need non-glucocorticoid forms of therapy to treat 21-hydroxylase deficiency congenital adrenal hyperplasia.The most common form of congenital adrenal hyperplasia (CAH) is a ...

Jamestown Regional Medical Center is proud to announce that it has been named one of the Top 20 Critical Access Hospitals ...

Medical leaders are worried about potential cuts to Critical Access Hospitals (CAH), a special designation given by the ...

Q1 2023 Earnings Call Transcript April 15, 2025 Spruce Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0 ...

A mighty gust of wind on a dreary morning only lifted the sail of the freshly cut ribbon, on Community Action House’s new set ...